The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.
 
Giuseppe Di Caro
Employment - Epic Sciences; Pfizer
Stock and Other Ownership Interests - Epic Sciences; Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
Travel, Accommodations, Expenses - Epic Sciences; Pfizer
 
Ernest Lam
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
David Bourdon
Employment - Epic Sciences
 
Tatjana Singer
No Relationships to Disclose
 
Kandra Horne
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Megan Slade
Employment - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Rick Wenstrup
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Honoraria - Developmental Dynamics, SD, CA
Consulting or Advisory Role - Developmental Dynamics, SD, CA
Research Funding - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Lee S. Schwartzberg
Consulting or Advisory Role - Abbvie; AstraZeneca; BeyondSpring Pharmaceuticals; BMSi; Coherus Biosciences; Daiichi Sankyo; Epic Sciences; Foundation Medicine; Genentech; GlaxoSmithKline; Helsinn Therapeutics; Lilly; Mirati Therapeutics; Myriad Genetics; Napo Pharmaceuticals; Novartis; Pfizer; Sandoz; Sanofi; Seagen; Spectrum Pharmaceuticals
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Merck; Pfizer; Seagen